Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Mangalam Organics Limited is an India-based specialty chemicals manufacturer focused on guanidine-based compounds, rubber chemicals, and agrochemical intermediates. The company operates manufacturing facilities in Gujarat and serves global markets including Europe, Asia, and the Americas. Recent 194% net income growth reflects margin expansion despite modest 7.4% revenue growth, though negative free cash flow of $0.8B indicates heavy capex investment phase.
Mangalam operates as a contract manufacturer and merchant producer of specialty chemicals with 48.4% gross margins indicating differentiated chemistry capabilities. Revenue comes from long-term supply contracts with agrochemical and pharmaceutical companies, plus spot sales of rubber chemicals tied to automotive production cycles. Pricing power derives from technical expertise in guanidine chemistry, regulatory approvals, and switching costs for validated suppliers in pharma/agro supply chains. The company benefits from India's cost-competitive manufacturing base while serving premium global markets.
Raw material cost inflation, particularly crude oil derivatives, benzene, and ammonia which are key feedstocks for guanidine and rubber chemical production
Global agrochemical demand cycles driven by crop prices, farmer economics, and generic agrochemical penetration in emerging markets
Automotive production volumes in Asia and Europe affecting rubber chemical demand, particularly tire manufacturing activity
Capacity utilization rates and commissioning timelines for new manufacturing lines given the current heavy capex phase
Chinese specialty chemical supply dynamics and anti-dumping regulations affecting competitive positioning
Environmental regulations tightening globally for chemical manufacturing, requiring ongoing capex for emissions control and waste treatment, particularly in Europe where key customers operate
Chinese competition in commodity specialty chemicals with lower cost structures, though offset partially by quality/regulatory advantages and anti-dumping protections
Agrochemical industry consolidation reducing number of potential customers and increasing buyer negotiating power
Dependence on technical differentiation in guanidine chemistry which could erode if competitors develop similar capabilities or alternative chemistries emerge
Customer concentration risk if top agrochemical or tire manufacturers backward integrate or diversify supplier base
Pricing pressure in rubber chemicals segment which has more commodity-like characteristics compared to pharma/agro intermediates
Negative free cash flow of $0.8B and operating cash flow of -$0.1B creates refinancing risk and limits financial flexibility during downturns
Heavy capex cycle ($0.7B) requires successful commercialization and capacity ramp to generate returns; execution delays would strain liquidity
1.14x debt/equity ratio manageable but concerning given negative cash generation; interest coverage depends on EBITDA stability
high - Rubber chemicals are directly tied to automotive production and tire replacement cycles, which are highly cyclical. Agrochemical intermediates correlate with global crop prices and farmer purchasing power. The 48.4% gross margin provides some buffer, but 7.1% operating margin leaves limited room for volume declines. Industrial production indices and manufacturing PMIs are leading indicators for demand.
Rising interest rates negatively impact the company through multiple channels: higher financing costs on the 1.14x debt/equity balance sheet, reduced valuation multiples for growth capex stories, and demand destruction in rate-sensitive end markets like automotive. The current negative free cash flow position makes the company dependent on external financing, amplifying rate sensitivity. However, India-specific rate dynamics matter more than US Federal Funds given domestic rupee debt.
Moderate credit exposure given 1.09x current ratio and negative operating cash flow. The company requires access to working capital facilities for raw material procurement and finished goods inventory. Tightening credit conditions in India or rising corporate bond spreads would increase financing costs and potentially constrain growth capex. Customer credit quality in agrochemical distribution channels also matters during agricultural downturns.
value - The 0.6x price/sales and 1.2x price/book ratios suggest deep value positioning despite 194% net income growth. The 8.7x EV/EBITDA is attractive for specialty chemicals. However, negative free cash flow and execution risk on capex ramp appeal to value investors willing to look through near-term cash burn for longer-term margin expansion. The -26.9% six-month decline has created contrarian opportunity for investors betting on capacity utilization improvement.
high - The stock exhibits significant volatility with -26.9% six-month drawdown followed by 10.2% one-year gain. Small-cap Indian specialty chemical companies face volatility from commodity input costs, currency fluctuations, and sentiment swings on China competition fears. Limited liquidity in the stock amplifies price moves. Beta likely exceeds 1.3 relative to Indian equity indices.